1 / 2

CADILLAC Trial Design

CADILLAC Trial Design. Controlled Abciximab and Device Investigation to Lower Late Angioplasty Combinations Randomized Comparison in the Setting of Acute MI. Age > 18 years Nitrate-unresponsive chest pain consistent with acute MI (duration > 30 min but < 12 hours)

amanda
Download Presentation

CADILLAC Trial Design

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CADILLAC Trial Design Controlled Abciximab and Device Investigation to Lower Late Angioplasty Combinations Randomized Comparison in the Setting of Acute MI Age > 18 years Nitrate-unresponsive chest pain consistent with acute MI (duration > 30 min but < 12 hours) Native coronary artery > 2.5 mm, < 4.0 mm Lesion length < 70 mm Stenting (+ abciximab) Balloon angioplasty (+ abciximab) vs Inclusion Criteria

  2. CADILLAC Trial Results Stenting +abciximab(n=525) PTCA +abciximab2(n=528 ) PTCA1,3(n=517 ) Stenting3(n=511 ) TIMI-3 flow 94% 92% 92% 96.7% Recurrent ischemia 4.5% 1.5% 3.9% 1.2% Mortality 1.4% 1.0% 1.6% 1.6% Need for ischemic TVR 2.3% 0.2% 0.8% 0.2% (1) 19.9% provisional stenting; (2) 15.0% provisional stenting; (3) about 5% crossover to abciximab Stone GR, et al. Presented at the AHA 72nd Scientific Sessions. November, 1999.

More Related